Urinary tract infections: pathogenesis, host susceptibility and emerging therapeutics
Nature Reviews Microbiology · 2025-02 · 23 (2) · 72-86
DOI: 10.1038/s41579-024-01092-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nature Reviews Microbiology, online erschienen am 09.09.2024. Verfasst von Morgan R Timm und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA. Hauptthemen laut MEDLINE: Urinary Tract Infections, Host-Pathogen Interactions. Die Arbeit wurde bisher 190-mal zitiert (Crossref) und nennt 177 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Urinary tract infections (UTIs), which include any infection of the urethra, bladder or kidneys, account for an estimated 400 million infections and billions of dollars in health-care spending per year. The most common bacterium implicated in UTI is uropathogenic Escherichia coli, but diverse pathogens including Klebsiella, Enterococcus, Pseudomonas, Staphylococcus and even yeast such as Candida species can also cause UTIs. UTIs occur in both women and men and in both healthy and immunocompromised patients. However, certain patient factors predispose to disease: for example, female sex, history of prior UTI, or the presence of a urinary catheter or other urinary tract abnormality. The current clinical paradigm for the treatment of UTIs involves the use of antibiotics. Unfortunately, the efficacy of this approach is dwindling as the prevalence of antimicrobial resistance rises among UTI isolates, and the immense quantity of antibiotics prescribed annually for these infections contributes to the emergence of resistant pathogens. Therefore, there is an urgent need for new antibiotics and non-antibiotic treatment and prevention strategies. In this Review, we discuss how recent studies of bacterial pathogenesis, recurrence, persistence, host-pathogen interactions and host susceptibility factors have elucidated new and promising targets for the treatment and prevention of UTIs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.
- Center for Women's Infectious Disease Research, Washington University School of Medicine, St. Louis, MO, USA.
- Department of Paediatrics, Washington University School of Medicine, St. Louis, MO, USA.
- Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA. hultgren@wustl.edu.
- Center for Women's Infectious Disease Research, Washington University School of Medicine, St. Louis, MO, USA. hultgren@wustl.edu.
Förderung
- NIAID NIH HHS
- NIDDK NIH HHS
Zitieren
APA
Timm, M. R., Russell, S. K., & Hultgren, S. J. (2025). Urinary tract infections: pathogenesis, host susceptibility and emerging therapeutics. Nature Reviews Microbiology, 23(2), 72-86. https://doi.org/10.1038/s41579-024-01092-4
Vancouver
Timm MR, Russell SK, Hultgren SJ. Urinary tract infections: pathogenesis, host susceptibility and emerging therapeutics. Nature Reviews Microbiology. 2025;23(2):72-86. doi:10.1038/s41579-024-01092-4
BibTeX
@article{Timm2025,
author = {Timm, Morgan R and Russell, Seongmi K and Hultgren, Scott J},
title = {Urinary tract infections: pathogenesis, host susceptibility and emerging therapeutics},
journal = {Nature Reviews Microbiology},
year = {2025},
volume = {23},
number = {2},
pages = {72--86},
doi = {10.1038/s41579-024-01092-4}
}
EUVIMED